English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Financial Daily Finance
具备价值支撑与定价能力,东软教育值得期待
Sep 30, 2020 15:03 HKT
具備價值支撐與定價能力,東軟教育值得期待
Sep 30, 2020 15:02 HKT
WeR1's Client SGX-Listed Sasseur REIT Wins Top IR Award For Second Consecutive Year
Sep 30, 2020 13:00 HKT
CWT INT'L完成債務重組 聚焦核心物流倉儲業務 迎接後疫情時代物流行業復甦
Sep 30, 2020 09:00 HKT
知臨集團開設傳染病液體活檢初創子公司,獨家獲得了新加坡Accelerate Technologies的許可以共同開發基於基因組分析以追蹤病原體基因組的快速分子病原體診斷技術
Sep 29, 2020 18:36 HKT
Aptorum Group Launches Infectious Disease Liquid Biopsy Subsidiary, Announces Exclusive In-license from Singapore-based Accelerate Technologies to Co-Develop Molecular Based Rapid Pathogen Diagnostics to Track Pathogenic Genome
Sep 29, 2020 18:35 HKT
竞争优势突出 快递龙头中通快递今日上市
Sep 29, 2020 11:47 HKT
競爭優勢突出 快遞龍頭中通快遞今日上市
Sep 29, 2020 11:46 HKT
君实生物特瑞普利单抗(拓益®)一线治疗鼻咽癌III期临床研究达到主要研究终点
Sep 29, 2020 09:48 HKT
Technoglobal引入AutoBio Inc.为策略顾问 为于香港上市作好准备
Sep 29, 2020 09:43 HKT
Technoglobal引入AutoBio Inc.為策略顧問 為於香港上市作好準備
Sep 29, 2020 09:42 HKT
Technoglobal Introduces AutoBio Inc. as Strategic Advisor Well Prepared for Listing in Hong Kong
Sep 29, 2020 09:40 HKT
中国纳泉能源科技控股有限公司公布于香港联合交易所有限公司主板上市计划详情
Sep 29, 2020 09:22 HKT
中國納泉能源科技控股有限公司公佈於香港聯合交易所有限公司主板上市計劃詳情
Sep 29, 2020 09:21 HKT
China Nature Energy Technology Holdings Limited Announces Details of Proposed Main Board listing on SEHK
Sep 29, 2020 09:20 HKT
宏基資本建議購回最多102,000,000股股份 要約價每股0.68港元 較最後交易日收市價溢價51.11%
Sep 29, 2020 09:01 HKT
Rykadan Capital Proposes Stock Buy-back of Up to 102,000,000 Shares at Offer Price of HK$0.68 Per Share, Equivalent to 51.11% Premium over the Closing Price on the Last Trading Day
Sep 29, 2020 09:00 HKT
疫情走了,资本来了,2020湖北·高质量发展资本大会正式开幕
Sep 28, 2020 21:06 HKT
疫情走了,資本來了,2020湖北·高質量發展資本大會正式開幕
Sep 28, 2020 21:05 HKT
内地工程机械蓬勃发展 津上精密机床工程机械相关订单攀升近140%
Sep 28, 2020 19:41 HKT
Next >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: